ライフサイエンスコーパス: Mycobacterium avium

1 tic plasmids from the opportunistic pathogen Mycobacterium avium.

2 was identified in the opportunistic pathogen Mycobacterium avium.

3 of TLR2 expression following infection with Mycobacterium avium.

4 variety of intracellular pathogens including Mycobacterium avium.

5 s tested, including Mycobacterium leprae and Mycobacterium avium.

6 ase mediated by the intramacrophage pathogen Mycobacterium avium.

7 TLR) 2 mRNA was induced after infection with Mycobacterium avium.

8 s virus stimulated by in vivo infection with Mycobacterium avium.

9 llowing infection of murine macrophages with Mycobacterium avium.

10 rium bovis bacillus Calmette-Guerin (BCG) or Mycobacterium avium.

11 It is about 100-fold less effective against Mycobacterium avium.

12 nt, phenol treatment, and contamination with Mycobacterium avium.

13 virulent (SmD) or virulent (SmT) variants of Mycobacterium avium 2-151.

14 ently were: Mycobacterium mucogenicum (52%), Mycobacterium avium (30%), and Mycobacterium gordonae (2

15 Infection of HIV-1-transgenic mice with Mycobacterium avium, a common opportunistic pathogen in

16 smegmatis and to a lesser extent pathogenic Mycobacterium avium, activate Ca(2+)-dependent calmoduli

17 restored antimycobacterial activity against Mycobacterium avium and Mycobacterium bovis Bacille Calm

18 thin 30 min and 30 to 60% after 3 h, whereas Mycobacterium avium and Mycobacterium fortuitum isolates

19 Mycobacterium avium and Mycobacterium intracellulare are

20 The clinical significance and prevalence of Mycobacterium avium and Mycobacterium intracellulare wer

21 Mycobacterium avium and Mycobacterium tuberculosis are h

22 olipids (GPLs), a major surface component of Mycobacterium avium and other non-tuberculosis mycobacte

23 s complex and to have homology with DNA from Mycobacterium avium and other nontuberculous mycobacteri

24 R2-dependent responses were seen using whole Mycobacterium avium and Staphylococcus aureus, demonstra

25 ples yielded cultures of Candida lusitaniae, Mycobacterium avium, and a filamentous fungus, Trichophy

26 lass II promoter (hu10Tg) were infected with Mycobacterium avium, and bacterial burdens and immune re

27 c infections caused by Pneumocystis carinii, Mycobacterium avium, and Campylobacter coli that require

28 /bg(-) mice were infected intravenously with Mycobacterium avium, and cultures of blood and brain as

29 7(-/-) and wild-type mice were infected with Mycobacterium avium, and host responses were analyzed.

30 er, Pneumocystis carinii, Toxoplasma gondii, Mycobacterium avium, and Lactobacillus casei) and showed

31 rol organisms included Mycobacterium simiae, Mycobacterium avium, and Mycobacterium xenopi.

32 Legionella pneumophila, Mycobacterium avium, and Pseudomonas aeruginosa are oppo

33 rtunistic pathogens (Legionella pneumophila, Mycobacterium avium, and Pseudomonas aeruginosa), broade

34 rom Pneumocystis carinii, Toxoplasma gondii, Mycobacterium avium, and rat liver.

35 Mycobacterium tuberculosis and Mycobacterium avium are facultative intracellular pathog

36 ag2(-/-)gammac(-/-) mice are as resistant to Mycobacterium avium as Rag2(-/-) mice, whereas Rag2(-/-)

37 duced in response to live M. tuberculosis or Mycobacterium avium as well as certain mycobacterial pro

38 CD43-transfected HeLa cells bound Mycobacterium avium, but not Salmonella typhimurium or S

39 ues from both Mycobacterium tuberculosis and Mycobacterium avium can complement lpqM donor mutants, s

40 Previous studies have demonstrated that Mycobacterium avium can invade intestinal epithelial cel

41 Mycobacterium avium causes disseminated disease in human

42 Mycobacterium avium causes disseminated infection in pat

43 against DHFR from both Toxoplasma gondii and Mycobacterium avium compared to mammalian DHFR.

44 rophages following infection with pathogenic Mycobacterium avium compared to the activation following

45 rophages infected with pathogenic strains of Mycobacterium avium compared with infections with the fa

46 The most common species recovered were Mycobacterium avium complex (69 isolates) and Mycobacter

47 Mycobacterium avium complex (72%) and Mycobacterium absc

48 (100%), CD4 cell count less than 200 (84%), Mycobacterium avium complex (73%), and Pneumocystis cari

49 We report a case of recurrent disseminated Mycobacterium avium complex (DMAC) disease with anti-gam

50 Whether infection with Mycobacterium avium complex (MAC) among patients with ac

51 e cases, 122 (64%) were culture-positive for Mycobacterium avium complex (MAC) and 69 (36%) for M. ab

52 Of 600 sets tested, 85 (14%) yielded Mycobacterium avium complex (MAC) and 9 (2%) yielded oth

53 In lymphoid tissues coinfected with Mycobacterium avium complex (MAC) and HIV-1, increased v

54 f 2,4-diamino-5-deazapteridine inhibitors of Mycobacterium avium complex (MAC) and human dihydrofolat

55 Members of the Mycobacterium avium complex (MAC) are important environm

56 Mycobacterium avium complex (MAC) are opportunistic resp

57 To determine the relationship between Mycobacterium avium complex (MAC) bacteremia and HIV RNA

58 type 1-infected persons with newly diagnosed Mycobacterium avium complex (MAC) bacteremia were enroll

59 Eight AIDS patients with Mycobacterium avium complex (MAC) bacteremia were random

60 y virus type 1 (HIV-1)-infected persons with Mycobacterium avium complex (MAC) bacteremia, the levels

61 reproducibility of susceptibility testing of Mycobacterium avium complex (MAC) by broth microdilution

62 r antimycobacterial therapy for disseminated Mycobacterium avium complex (MAC) could be withdrawn fro

63 n alone and in combination for prevention of Mycobacterium avium complex (MAC) disease were compared

64 in is a major drug used for the treatment of Mycobacterium avium complex (MAC) disease, but standard

65 Among MSM, the most frequent OIs were Mycobacterium avium complex (MAC) disease, Pneumocystis

66 effective drug regimens for the treatment of Mycobacterium avium complex (MAC) disease.

67 Although opportunistic infections due to Mycobacterium avium complex (MAC) have been less common

68 Persistent growth of Mycobacterium avium complex (MAC) in the lungs indicates

69 Mycobacterium avium complex (MAC) infection is the most

70 The relationship between Mycobacterium avium complex (MAC) infection of blood and

71 The Mycobacterium avium complex (MAC) is an important cause

72 The Mycobacterium avium complex (MAC) is an important group

73 Lung disease caused by Mycobacterium avium complex (MAC) is increasing in preva

74 Rapid identification of Mycobacterium avium complex (MAC) is possible by use of

75 robiologic cure of AIDS-related disseminated Mycobacterium avium complex (MAC) is possible in patient

76 Mycobacterium avium complex (MAC) is the most common dis

77 Mycobacterium avium complex (MAC) isolates among patient

78 features and outcome of macrolide-resistant Mycobacterium avium complex (MAC) lung disease are not k

79 in prospective macrolide treatment trials of Mycobacterium avium complex (MAC) lung disease were asse

80 household water sources for 36 patients with Mycobacterium avium complex (MAC) lung disease were eval

81 cs and to evaluate relapses in patients with Mycobacterium avium complex (MAC) lung disease, but the

82 atment of noncavitary nodular bronchiectatic Mycobacterium avium complex (MAC) lung disease, supporti

83 Organisms within the Mycobacterium avium complex (MAC) may have differential

84 Mycobacterium avium complex (MAC) organisms cause dissem

85 The clinical significance of recovery of Mycobacterium avium complex (MAC) organisms from respira

86 The numbers of isolates of Mycobacterium avium complex (MAC) recovered were 172 (10

87 Species identification of isolates of the Mycobacterium avium complex (MAC) remains a difficult ta

88 Adherence of Mycobacterium avium complex (MAC) to human respiratory e

89 Mycobacterium avium complex (MAC) within macrophages und

90 actors that contribute to protection against Mycobacterium avium complex (MAC), cytokine production b

91 genetically similar to other members of the Mycobacterium avium complex (MAC), some of which are non

92 y (HAART) on cell-mediated immunity (CMI) to Mycobacterium avium complex (MAC), we measured immune re

93 Organisms in the Mycobacterium avium complex (MAC; M. avium, M. intracell

94 ow-growing species, including members of the Mycobacterium avium complex (MAVC).

95 s with Emberger syndrome, monocytopenia with Mycobacterium avium complex (MonoMAC), and MDS.

96 mocystis carinii (n = 26), bacteria (n = 3), Mycobacterium avium complex (n = 2), Nocardia sp. (n = 1

97 l disease (mean number of organs infected by Mycobacterium avium complex 4.1 [SD 0.8] vs 2.0 [1.1], p

98 tory pulmonary nontuberculous mycobacterial (Mycobacterium avium complex [MAC] or Mycobacterium absce

99 One hundred isolates of Mycobacterium avium complex and eight M. simiae isolates

100 Prophylaxis against Mycobacterium avium complex can safely be withdrawn or w

101 Mycobacterium avium complex cultures, CD4(+) cell counts

102 ttributable to cytomegalovirus retinitis and Mycobacterium avium complex declined over time (p=0.0058

103 Calif.) to detect Mycobacterium gordonae and Mycobacterium avium complex directly in liquid medium fl

104 Several agents are effective in preventing Mycobacterium avium complex disease in patients with adv

105 phylaxis versus withdrawal for prevention of Mycobacterium avium complex disease.

106 g the pseudocording, or loose aggregation of Mycobacterium avium complex from M. tuberculosis and the

107 safety of discontinuing prophylaxis against Mycobacterium avium complex has been uncertain.

108 yelitis (patient 1) and disseminated CMV and Mycobacterium avium complex infection (patient 2), respe

109 IS event in HIV-infected patients, unmasking Mycobacterium avium complex infection after starting ant

110 The Mycobacterium avium complex is a source of disseminated

111 Infection with Mycobacterium avium complex is acquired from the environ

112 A major phenotypic trait of the Mycobacterium avium complex is the ability to produce ro

113 were evaluated for susceptibility testing of Mycobacterium avium complex isolates against clarithromy

114 ribosomal internal transcribed spacer of 56 Mycobacterium avium complex isolates from pediatric pati

115 g activities seem not to be risk factors for Mycobacterium avium complex lung disease in HIV-negative

116 Mycobacterium avium complex lung disease is an increasin

117 omponent of multidrug treatment regimens for Mycobacterium avium complex lung disease.

118 ia, esophageal candidiasis, and disseminated Mycobacterium avium complex or Mycobacterium kansasii in

119 Ten of 639 MGIT cultures grew Mycobacterium avium complex or Mycobacterium kansasii, h

120 hose previously treated for tuberculosis and Mycobacterium avium complex predominated (27.7% [95% CI:

121 Mycobacterium avium complex pulmonary disease (MAC-PD) i

122 new therapy for Candida esophagitis, whereas Mycobacterium avium complex therapy may be discontinued

123 Mycobacterium avium complex was concomitantly isolated i

124 Mycobacterium avium complex was seen in 75% of NTM-posit

125 Isolates of the Mycobacterium avium complex were examined for hemolysin

126 Nearly 60% of positive cultures were for Mycobacterium avium complex, although this ranged by sta

127 , 14% (1/7) for Cryptococcus, 10% (1/10) for Mycobacterium avium complex, and 4% (3/72) for PCP.

128 ifferent Mycobacterium tuberculosis complex, Mycobacterium avium complex, and Mycobacterium spp. dire

129 neumocystis jeroveci pneumonia, disseminated Mycobacterium avium complex, lymphoid interstitial pneum

130 e closely related organisms and comprise the Mycobacterium avium complex.

131 tis carinii pneumonia [PCP] and disseminated Mycobacterium avium-complex [MAC] infection) in persons

132 HIV-infected patients with untreated Mycobacterium avium-complex diarrhea are associated with

133 ents and household water/biofilm isolates of Mycobacterium avium could be matched by DNA fingerprinti

134 Of the two common morphotypes of Mycobacterium avium, designated smooth transparent (SmT)

135 Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium DHFR vs rat DHFR.

136 hat represent 46 genes that are expressed by Mycobacterium avium during growth in human macrophages.

137 tosporidium parvum, Enterocytozoon bieneusi, Mycobacterium avium, Entamoeba histolytica, Balantidium

138 imensional gel electrophoresis revealed that Mycobacterium avium expresses several proteins unique to

139 n binding motif of the previously identified Mycobacterium avium fibronectin attachment protein (FAP-

140 ate of MTB from a nonTB species of the genus Mycobacterium avium grown in liquid culture media.

141 ating inflammation induced by infection with Mycobacterium avium in human primary macrophages.

142 vation of Janus Kinase (JAK)-STAT pathway in Mycobacterium avium-infected macrophages.

143 Here, we show that Mycobacterium avium-infected T cell-deficient mice injec

144 Disseminated Mycobacterium avium infection is common in AIDS patients

145 Active disseminated Mycobacterium avium infection may significantly compromi

146 We previously reported that Mycobacterium avium infection of mouse macrophages decre

147 Disseminated Mycobacterium avium infection persisted and the patient

148 In this study, 30 AIDS patients without Mycobacterium avium infection were randomized to receive

149 ceptor (TLR) signaling in host resistance to Mycobacterium avium infection, mice deficient in the TLR

150 Here, we report on a patient with Mycobacterium avium infection, recurrent Staphylococcus

151 ere we show, using an in vivo mouse model of Mycobacterium avium infection, that an increased proport

152 Using the mouse model of Mycobacterium avium infection, we show in this study tha

153 d whether ISS-ODN could modify the course of Mycobacterium avium infection.

154 s evaluated in a mouse model of disseminated Mycobacterium avium infection.

155 sis pulmonary hypersensitive pneumonitis and Mycobacterium avium infections.

156 Isolates of Mycobacterium avium-intracellulare (MAI) form multiple c

157 Mycobacterium avium-intracellulare complex (MAC) is one

158 that most resemble Mycobacterium simiae and Mycobacterium avium-intracellulare complex but which pos

159 These included a psoas abscess secondary to Mycobacterium avium-intracellulare, septic wrist, bacter

160 Mycobacterium avium is a common opportunistic infection

161 Invasion of intestinal mucosa of the host by Mycobacterium avium is a critical step in pathogenesis a

162 Mycobacterium avium is a facultative intracellular patho

163 Mycobacterium avium is a major opportunistic pathogen in

164 Mycobacterium avium is a major opportunistic pathogen of

165 Mycobacterium avium is abundant in the environment.

166 Mycobacterium avium is an intracellular pathogen that ha

167 Mycobacterium avium is an opportunistic pathogen in AIDS

168 Mycobacterium avium is capable of invading the intestina

169 terium tuberculosis, Mycobacterium leprae or Mycobacterium avium is correlated with strong inflammato

170 The cell wall of the environmental pathogen Mycobacterium avium is important to its virulence and in

171 Mycobacterium avium is the most frequent cause of dissem

172 The role of Mycobacterium avium isolates in modulating human immunod

173 The LRF patterns of Mycobacterium avium isolates recovered from potable wate

174 Mycobacterium avium (M. avium) subspecies vary widely in

175 pj), Toxoplasma gondii (T. gondii, tg), and Mycobacterium avium (M. avium, ma) are the principal cau

176 vide a tool to better understand the role of Mycobacterium avium-M. intracellulare complex isolates i

177 The 159 Mycobacterium avium-M. intracellulare complex isolates w

178 Additional differentiation of Mycobacterium avium-M. intracellulare complex strains in

179 cystis carinii (Pc), Toxoplasma gondii (Tg), Mycobacterium avium (Ma), and rat liver in comparison wi

180 is carinii (Pc), Toxoplasma gondii (Tg), and Mycobacterium avium (Ma), three life-threatening pathoge

181 is carinii (Pc), Toxoplasma gondii (Tg), and Mycobacterium avium (Ma), three of the opportunistic org

182 is carinii (Pc), Toxoplasma gondii (Tg), and Mycobacterium avium (Ma), three of the opportunistic pat

183 r activity against M. tuberculosis (Mtb) and Mycobacterium avium (MAC) are reported.

184 arinii (pcDHFR), Toxoplasma gondii (tgDHFR), Mycobacterium avium (maDHFR), and rat liver (rlDHFR).

185 fected with different mycobacterial strains (Mycobacterium avium, Mycobacterium bovis BCG or Mtb), we

186 erium smegmatis, Mycobacterium tuberculosis, Mycobacterium avium, Mycobacterium gadium and Mycobacter

187 PP (Legionella spp., Legionella pneumophila, Mycobacterium avium, Mycobacterium intracellulare, Pseud

188 Mycobacterium avium, Mycobacterium tuberculosis, and Myc

189 Infection of mice with Mycobacterium avium or immunization with a novel PE gene

190 lpha) production in macrophage infected with Mycobacterium avium or M smegmatis is dependent on myelo

191 erived macrophages were infected with either Mycobacterium avium or Mycobacterium tuberculosis and th

192 Later, the mice received Mycobacterium avium or Mycobacterium tuberculosis I.T.

193 nse in the thymus following dissemination of Mycobacterium avium or Mycobacterium tuberculosis.

194 drome, and opportunistic infections, such as Mycobacterium avium or Pneumocystis carinii infections.

195 sease in humans have led to speculation that Mycobacterium avium paratuberculosis (MAP) might be a ca

196 When tested against Mycobacterium avium, PCIH was more effective than INH at

197 A structural genomics protein from Mycobacterium avium (PDB ID 3q1t) has been reported to b

198 The role that colonization with Mycobacterium avium plays in the development of dissemin

199 hat primary murine macrophages infected with Mycobacterium avium produced lower levels of tumor necro

200 T cells from mice infected with Mycobacterium avium responded to FAP-A, suggesting a pos

201 primary murine macrophages had no effect on Mycobacterium avium retention in an early endosomal comp

202 human macrophages respond to infection with Mycobacterium avium, serovar 4, by producing tumor necro

203 olipids (GPLs), a major surface component of Mycobacterium avium, showed limited acidification and de

204 cal survey of distribution in Great Britain, Mycobacterium avium ssp. paratuberculosis (MAP) was dete

205 time in macrophages infected with pathogenic Mycobacterium avium strains relative to infections with

206 say that uses a unique element (ISMap02) for Mycobacterium avium sub0:36 PMparatuberculosis that is p

207 Mycobacterium avium subsp hominissuis is associated with

208 Johnes disease (JD), caused by Mycobacterium avium subsp paratuberculosis (MAP), occurs

209 evaluated for growth stimulating behavior in Mycobacterium avium subsp paratuberculosis.

210 obacterium avium subsp. paratuberculosis and Mycobacterium avium subsp. avium are antigenically and g

211 obacterium avium subsp. paratuberculosis and Mycobacterium avium subsp. avium are antigenically and g

212 tories has shown >98% sequence identity with Mycobacterium avium subsp. avium in some regions.

213 of Mycobacterium avium subsp. silvaticum and Mycobacterium avium subsp. avium, and a single isolate e

214 Mycobacterium avium subsp. hominissuis is an opportunist

215 "Mycobacterium avium subsp. hominissuis" is a robust and

216 "Mycobacterium avium subsp. hominissuis" is an opportunis

217 cosa by M. avium subsp. paratuberculosis and Mycobacterium avium subsp. hominissuis, a pathogen known

218 egration loci of IS900 (loci L1 and L9), one Mycobacterium avium subsp. paratuberculosis (M. paratube

219 R) sequencing approach for the genotyping of Mycobacterium avium subsp. paratuberculosis (M. paratube

220 Presently, no drugs against Mycobacterium avium subsp. paratuberculosis (M. paratube

221 ing affinity of Ag85A, Ag85B, and Ag85C from Mycobacterium avium subsp. paratuberculosis (MAP) (K(D)

222 protocol was optimized for the isolation of Mycobacterium avium subsp. paratuberculosis (MAP) from m

223 Available diagnostic assays for Mycobacterium avium subsp. paratuberculosis (MAP) have p

224 r regulatory mechanisms of host responses to Mycobacterium avium subsp. paratuberculosis (MAP) infect

225 To investigate the stochastic dynamics of Mycobacterium avium subsp. paratuberculosis (MAP) infect

226 Johne's disease is caused by Mycobacterium avium subsp. paratuberculosis (MAP) infect

227 Mycobacterium avium subsp. paratuberculosis (MAP), a slo

228 = 128), Mycobacterium kansasii (n = 10), and Mycobacterium avium subsp. paratuberculosis (n = 10), ca

229 SOD], and 35-kDa protein) were purified from Mycobacterium avium subsp. paratuberculosis and evaluate

230 Little is known of protein expression in Mycobacterium avium subsp. paratuberculosis and how this

231 nce repeats (SSRs) of 211 and 56 isolates of Mycobacterium avium subsp. paratuberculosis and M. avium

232 Mycobacterium avium subsp. paratuberculosis and Mycobact

233 Mycobacterium avium subsp. paratuberculosis and Mycobact

234 The genetic similarity between Mycobacterium avium subsp. paratuberculosis and other my

235 made between PBMCs stimulated in vitro with Mycobacterium avium subsp. paratuberculosis and PBMCs st

236 = 39) were tested for the presence of viable Mycobacterium avium subsp. paratuberculosis by a novel p

237 Efficient attachment and ingestion of Mycobacterium avium subsp. paratuberculosis by cultured

238 Attachment and ingestion of Mycobacterium avium subsp. paratuberculosis by two epith

239 Mycobacterium avium subsp. paratuberculosis causes an en

240 Mycobacterium avium subsp. paratuberculosis causes Johne

241 Mycobacterium avium subsp. paratuberculosis causes Johne

242 Infection with Mycobacterium avium subsp. paratuberculosis causes Johne

243 With the genome sequence of Mycobacterium avium subsp. paratuberculosis determined,

244 ism (AFLP) to characterize the genomes of 20 Mycobacterium avium subsp. paratuberculosis field isolat

245 the isolation, separation, and detection of Mycobacterium avium subsp. paratuberculosis from milk an

246 Mycobacterium avium subsp. paratuberculosis has been inc

247 The infection biology of Mycobacterium avium subsp. paratuberculosis has recently

248 Interactions between epithelium and Mycobacterium avium subsp. paratuberculosis have not bee

249 orescent probes (molecular beacons) detected Mycobacterium avium subsp. paratuberculosis in bovine fe

250 Mycobacterium avium subsp. paratuberculosis infection of

251 Mycobacterium avium subsp. paratuberculosis infection of

252 sensitivity and reduce time to diagnosis of Mycobacterium avium subsp. paratuberculosis infection.

253 In the present study, instillation of Mycobacterium avium subsp. paratuberculosis into the ton

254 and veterinary Johne's disease suggests that Mycobacterium avium subsp. paratuberculosis is a causati

255 Infection with Mycobacterium avium subsp. paratuberculosis is associate

256 Mycobacterium avium subsp. paratuberculosis is genetical

257 Mycobacterium avium subsp. paratuberculosis is shed into

258 Mycobacterium avium subsp. paratuberculosis is the causa

259 Mycobacterium avium subsp. paratuberculosis is the causa

260 Mycobacterium avium subsp. paratuberculosis is the cause

261 Analysis of short sequence repeats of Mycobacterium avium subsp. paratuberculosis isolated fro

262 lar diversity of animal and human strains of Mycobacterium avium subsp. paratuberculosis isolated in

263 for the study of the genetic relatedness of Mycobacterium avium subsp. paratuberculosis isolates har

264 s, infection with the intracellular pathogen Mycobacterium avium subsp. paratuberculosis results in a

265 nd/or enrichment methods on the selection of Mycobacterium avium subsp. paratuberculosis subtypes.

266 Attachment of Mycobacterium avium subsp. paratuberculosis to host tiss

267 Five pigmented isolates of Mycobacterium avium subsp. paratuberculosis were examine

268 luate whether cows that were low shedders of Mycobacterium avium subsp. paratuberculosis were passive

269 Mycobacterium avium subsp. paratuberculosis, the agent o

270 omprised of crude whole-cell preparations of Mycobacterium avium subsp. paratuberculosis.

271 ease in cattle requires antigens specific to Mycobacterium avium subsp. paratuberculosis.

272 ntrol of mycobacterial infections, including Mycobacterium avium subsp. paratuberculosis.

273 The causative agent of Johne's disease is Mycobacterium avium subsp. paratuberculosis.

274 atuberculosis isolates, two isolates each of Mycobacterium avium subsp. silvaticum and Mycobacterium

275 MAP and Mycobacterium avium subspecies avium, a closely related

276 The role of Mycobacterium avium subspecies paratuberculosis (MAP) in

277 sheep, is caused by slow replicating bacilli Mycobacterium avium subspecies paratuberculosis (MAP) in

278 omplete genome sequence of a common clone of Mycobacterium avium subspecies paratuberculosis (Map) st

279 Mycobacterium avium subspecies paratuberculosis (MAP), t

280 By the analysis of 14 SNPs Mycobacterium avium subspecies paratuberculosis isolates

281 uipment for the large-scale global typing of Mycobacterium avium subspecies paratuberculosis isolates

282 erformed using genome sequence data from 133 Mycobacterium avium subspecies paratuberculosis isolates

283 g-chain acyl-CoA carboxylase holoenzyme from Mycobacterium avium subspecies paratuberculosis revealed

284 Typing of Mycobacterium avium subspecies paratuberculosis strains

285 A number of intestinal pathogens including Mycobacterium avium subspecies paratuberculosis, adheren

286 ed possibilities for the characterization of Mycobacterium avium subspecies paratuberculosis, and who

287 acillary paratuberculosis are both caused by Mycobacterium avium subspecies paratuberculosis.

288 guinea pigs were infected with M. bovis BCG, Mycobacterium avium, the attenuated Mycobacterium tuberc

289 Mycobacterium avium, the most common opportunistic patho

290 however, even within a single subspecies of Mycobacterium avium these lipids can differ.

291 ed mouse macrophages to resist the growth of Mycobacterium avium via alpha(2)-adrenergic stimulation.

292 nce strain 104 of the opportunistic pathogen Mycobacterium avium was isolated from an adult AIDS pati

293 effect described in macrophages infected by Mycobacterium avium was not observed in our model, which

294 While Mycobacterium avium was once regarded as innocuous, its

295 Mycobacterium avium was recovered from 41 specimens; 36

296 f the fibrinolytic system and infectivity by Mycobacterium avium were analyzed.

297 pportunistic pathogens Toxoplasma gondii and Mycobacterium avium when administered via the i.p. or i.

298 e demonstrated improved growth inhibition of Mycobacterium avium when incubated with exogenous granul

299 s contrasted with Gram-positive bacteria and Mycobacterium avium, which activated cells via TLR2 but

300 valuated the effect of iron on the growth of Mycobacterium avium within macrophages as well as on the